FDA Import Refusal 799-1899176-2/51/1 — TORRENT PHARMACEUTICAL LTD
The FDA refused shipment 799-1899176-2/51/1 from TORRENT PHARMACEUTICAL LTD (India) on Jul 30, 2024. The refused product falls under Drugs and Biologics — DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal details
- Date
- Jul 30, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62ODA24 DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75